Identification of alterations in the cellular composition of the human immune system is key to 38 understanding the autoimmune process. Recently, a subset of FOXP3 + cells with low CD25 39 expression was found to be increased in peripheral blood from systemic lupus erythematosus 40 (SLE) patients, although its functional significance remains controversial. Here we find in 41 comparisons with healthy donors that the frequency of FOXP3 + cells within 42 CD127 low CD25 low CD4 + T cells (here defined as CD25 low FOXP3 + T cells) is increased in 43 patients affected by autoimmune disease of varying severity, from combined 44 immunodeficiency with active autoimmunity, SLE to type 1 diabetes. We show that 45 CD25 low FOXP3 + T cells share phenotypic features resembling conventional 46 CD127 low CD25 high FOXP3 + Tregs, including demethylation of the Treg-specific epigenetic 47 control region in FOXP3 that is highly enriched in HELIOS + cells, and lack of IL-2 48 production. As compared to conventional Tregs, more CD25 low FOXP3 + HELIOS + T cells are 49 in cell cycle (33.0% vs 20.7% Ki-67 + ; P = 1.3 x 10 -9 ) and express the late-stage inhibitory 50 receptor PD-1 (67.2% vs 35.5%; P = 4.0 x 10 -18 ), while having reduced expression of the 51 early-stage inhibitory receptor CTLA-4, as well as other Treg markers, such as FOXP3 and 52 CD15s. The number of CD25 low FOXP3 + T cells are highly correlated (P = 1.2 x 10 −19 ) with 53 the proportion of CD25 high FOXP3 + T cells in cell cycle (Ki-67 + ). These findings suggest that 54 CD25 low FOXP3 + T cells represent a subset of Tregs that are derived from CD25 high FOXP3 + T 55 cells, and are a peripheral marker of recent Treg expansion in response to an autoimmune 56 reaction in tissues. 57 58 Keywords: Regulatory T cells (Tregs); Autoimmunity; FOXP3; Treg-specific demethylated 59 region (TSDR); CD25. 60 [5-9], a finding that was later expanded to the peripheral blood of multiple sclerosis [10] and 78 rheumatoid arthritis [11] patients. The frequency of this cell subset has been demonstrated to 79
memory Tregs that are actively recruited to peripheral compartments to suppress immune 66 responses against self and maintain tissue integrity [2] . It is becoming increasingly apparent 67 that there is considerable heterogeneity in memory Treg subsets in humans [3, 4] . One major 68 challenge for studying human Tregs is that normally only peripheral blood cells from patients 69 are available, rather than the effector T cells and Tregs present in the inflamed tissue and 70 associated lymph nodes. A better understanding of the composition of the Treg compartment 71 in peripheral blood is therefore needed to investigate the potential contribution to disease 72 mechanisms made by Tregs and to identify cellular alterations of the peripheral compartment 73 associated with the onset of pathogenic autoimmune manifestations in the tissues. 74
75
Recently, a novel subset of FOXP3 + cells with low expression of CD25 was reported to be 76 increased in peripheral blood of autoimmune systemic lupus erythematosus (SLE) patients 77 7 unaffected siblings were individuals without autoimmune disease (self-reported). Baseline 118 characteristics for all participating subjects are summarised in Table 1 Total PBMCs from seven healthy CBR donors (three males and four females) were stained 172 with fluorophore-conjugated antibodies (see Supplementary Table 1 ) and sorted using a BD 173 Aria Fusion flow cytometer (BD Biosciences). Methylation of the FOXP3 TSDR was 174 performed using a next-generation sequencing method, as described previously [16] . was calculated using two-tailed unpaired student's t-tests. The effects of age, sex and time of 180 collection were controlled by the experimental design used in this study and, therefore, not 181 included as additional covariates. Given that most immune phenotypes showed moderate to 182 strong right skew that violated the assumption of normality, the phenotypes were log-183 highly increased in CD127 low cells of some patients. We found that among SLE and CID 201 patients with increased CD127 low FOXP3-expressing cells there is a notable loss of CD25 202 expression, which results in an extremely high frequency of CD127 low CD25 low FOXP3 + cells 203 ( Fig. 1A) . These findings suggest that the frequency of FOXP3 + cells in the 204 CD127 low CD25 low T cell subset (CD25 low FOXP3 + cells; depicted in red in Fig. 1B) is 205 increased as a result of an active autoimmune response and could be a specific marker of 206 Treg activation. Given the lack of peripheral markers that reflect chronic immune activation, 207
we therefore decided to focus our analysis on this population of CD25 low FOXP3 + cells, and 208 investigate their frequency in the peripheral blood of autoimmune patients. 209
210
Consistent with previous findings [7, 8] , we confirmed that the frequency of FOXP3 + cells 211 among CD127 low CD25 low T cells (gating strategy Fig. 1B ) was markedly increased in SLE 212 patients (geometric mean (GeoM) = 13.53%) compared to age-and sex-matched healthy 213 controls (5.51%, P = 2.1 x 10 -5 , N = 24, Fig. 1C ), which likely reflects the systemic immune 214 activation in SLE patients. In support of this hypothesis, we also detected a high frequency 215 of CD25 low FOXP3 + cells in a small cohort of seven CID patients, characterised by severe 216 active autoimmunity compared to age-and sex-matched healthy controls (12.14% and 4.00%, 217 respectively, P = 6.5 x 10 -3 ; Fig. 1C) . 218
219
We also found that the frequency of FOXP3 + cells among CD127 low CD25 low T cells was 220 significantly increased in T1D patients (6.84%) compared to age-and sex-matched healthy 221 controls (4.55%; P = 2.7 x 10 -6 ; Fig. 1D ). This association was also observed when 222 comparing the frequency of CD25 low FOXP3 + cells within total CD4 + T cells (0.32% vs 223 0.23% in T1D patients and controls, respectively; P = 1.1 x 10 -3 ; Supplementary Fig. 1A) , 224
and was not associated with duration of disease, ranging from 2 months to 23 years (P = 225 0.61). We replicated the finding of increased FOXP3 + cells among CD127 low CD25 low T cells 226 in an independent cohort of 15 long-standing T1D patients (10.39%) and 15 age-and sex-227 matched healthy controls (6.29%; P = 7.7 x 10 -3 ; Supplementary Fig. 1B ). Furthermore, we 228 noted that the increased frequency of FOXP3 + cells was mainly restricted to the 229 CD127 low CD25 low T cell subset, as we observed only a small increased frequency of 230 conventional CD127 low CD25 high FOXP3 + Tregs in T1D patients (5.55%) compared to healthy 231 donors (4.82%; P = 8.0 x 10 -3 ; Supplementary Fig. 2) . 232 233
CD25 low FOXP3 + cells are demethylated at the FOXP3 TSDR. 234
In humans FOXP3 is not exclusively expressed in Tregs, but can also be transiently up-235 regulated in activated Teffs. However, in thymically-derived Tregs constitutive expression of 236
FOXP3 is known to require a demethylated TSDR [2]. To assess the TSDR methylation 237 profile of CD25 low FOXP3 + cells we sorted these cells from four healthy donors, and 238 compared the methylation of the TSDR in CD25 low FOXP3 + cells, conventional 239 CD25 high FOXP3 + Tregs and the respective FOXP3 − subsets ( Fig. 2A) . We found that the 240 majority of CD25 low FOXP3 + cells were demethylated at the TSDR (Fig. 2B,C) Notably, the expression of FOXP3 was markedly lower in CD25 low FOXP3 + HELIOS − T cells 311 (MFI = 952), which is consistent with their methylated TSDR ( Supplementary Fig. 3) . 312 Furthermore, analysis of CD45RA + expression revealed a significantly lower frequency of 313 CD45RA + cells within total CD25 low FOXP3 + HELIOS + cells (4.7%) compared to their 314 CD25 high counterparts (20.8%; P = 2.0 x 10 -12 ; Supplementary Fig. 3) . These data suggest 315 that most of the CD45RA + cells observed within CD25 low FOXP3 + T cells are memory 316 effector T cells that have re-expressed CD45RA on their surface and are characterized by 317 being HELIOS − and expressing lower levels of FOXP3. Finally, since it was possible that the 318 expansion of CD25 low FOXP3 + HELIOS − cells (most of which lack a demethylated TSDR and 319 might be activated effector cells) could have been responsible for the increase of 320 CD25 low FOXP3 + cells in autoimmune patients (Fig. 1B,C) , we examined the distribution of 321 HELIOS + and HELIOS − cells within the CD25 low FOXP3 + subset. We determined that 322 HELIOS + CD25 low FOXP3 + cells were increased in SLE, CID and T1D patients as compared 323 to their healthy control cohorts ( Supplementary Fig. 4A,B ) similar to the findings with 324 CD25 low FOXP3 + cells (Fig. 1C,D) and that HELIOS + cells contributed significantly to all 325 cohorts examined ( Supplementary Fig. 4C,D) . 326 327
Low IL-2 production from HELIOS + CD45RA − CD25 low FOXP3 + cells. 328
To characterise the function of HELIOS + CD45RA − CD25 low FOXP3 + cells, we assessed the 329 production of two key cytokines, IL-2 and IFN-γ, in ten donors (five T1D patients and five 330 healthy controls) following in vitro stimulation ( Fig. 6) . Consistent with their Treg-like 331 phenotype, we found that both the HELIOS + CD45RA − CD25 low FOXP3 + and 332 CD25 high FOXP3 + subsets, which are highly demethylated at the TSDR (Fig. 5A) , showed a 333 low frequency of IL-2 + (2.0% and 1.0%, respectively) and IFN-γ + cells (5.1% and 1.4%, 334 respectively; Fig. 6B,C) . This was in marked contrast with the HELIOS + CD25 low FOXP3 − subset, which was found to secrete significantly higher levels of both IL-2 (21.3%; P = 2.8 x 336 10 -5 ; Fig. 6B ) and IFN-γ (27.9%; P = 1.1 x 10 -3 ; Fig. 6C ), compared their FOXP3 + 337 counterparts (2.0% and 5.1% for IL-2 and IFN-γ, respectively). In agreement with their 338 regulatory phenotype, we found a strong reduction of IL-2 + and IFN-γ + cells (2.0% and 5.1%, 339 respectively) in HELIOS + CD45RA − CD127 low CD25 low FOXP3 + cells compared to 340 conventional Teffs (59.8%, P = 5.3 x 10 -9 and 63.5%, P = 2.0 x 10 -7 for IL-2 + and IFN-γ + 341 cells, respectively; Fig. 6B,C) . 342
343
As compared to the HELIOS + fraction, we found that a higher portion of HELIOS − 344 CD45RA − CD25 low FOXP3 + cells produced IFN-γ ( Fig. 6A, Supplementary Fig. 5A ). These 345 findings are consistent with a previous study, showing that HELIOS − FOXP3 + T cells 346 produced IFN-γ, and were increased among T1D patients [17] . Although we found no 347 evidence for differential IFN-γ production in T1D patients compared to healthy controls 348 among HELIOS − CD45RA − CD127 low CD25 low FOXP3 + cells, on a per cell basis 349 ( Supplementary Fig. 5B ), the higher frequency of the CD25 low FOXP3 + subset among 350 patients resulted in a significant increase in the frequency of circulating FOXP3 + cells with 351 the capability to produce IFN-γ following stimulation among total CD4 + T cells (P = 2.5 x 352 10 -3 ; Supplementary Fig. 5C) compartment and ultimately to cell death. We assessed the total numbers of CD45RA − Ki-365 67 + Tregs both in the cohort of 24 healthy volunteers (cohort 1) and in an independent 366 replication cohort (cohort 2) of 112 healthy volunteers. We found that the frequency of 367 
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380
The identification of reliable biomarkers of disease activity has been a major challenge of 381 autoimmune diseases, particularly in organ-specific diseases, such as T1D, where there is 382 limited access to the inflamed tissues. In this study we characterised a subset of FOXP3 + 383 CD127 low CD25 low T cells, and show that it could be a peripheral biomarker of a recent 384 autoimmune reaction in the tissues. We showed that in addition to SLE, where the increase 385 of FOXP3 + CD25 low T cells has been observed in multiple SLE studies [5-9], the proportion 386 of FOXP3 + cells in the CD127 low CD25 low subset is increased in CID and T1D patients. 387
Although the frequency of FOXP3 + cells in the CD127 low CD25 low subset was compared in 388 T1D patients versus controls in one previous study with no difference observed [13], we note 389 that the number of participants was small: 10 healthy control individuals and 16 patients. In 390 contrast, Zoka et al [18] observed that the proportion of CD25 low cells among FOXP3 + CD4 + 391 T cells is higher in T1D patients than in controls, a phenotype consistent with our 392 observations. 393
394
A major strength of this study is that we were able to use a recently developed assay [16] to 395 precisely assess the methylation status of the FOXP3 TSDR of CD25 low FOXP3 + cells, a 396 feature that was lacking in the previous SLE studies [7, 8] respectively). We went on to define that this epigenetic similarity was caused primarily by 402 the TSDR methylation status of HELIOS + cells: virtually all HELIOS + cells were found to be demethylated in both the CD25 high and CD25 low FOXP3 + subsets. This finding is consistent 404 with a previous study assessing the FOXP3 TSDR methylation profile in different 405 CD4 + CD127 low T-cell subsets discriminated by their expression of FOXP3 and CD25 [19] . 406
The majority of CD25 low FOXP3 + cells sorted from synovial fluid mononuclear cells of 407 juvenile idiopathic arthritis patients were shown to have a demethylated FOXP3 TSDR, 408
suggesting that this subset may be enriched at inflammatory sites [19] . In the current study 409 we also found that the proportion of cells expressing TIGIT was elevated over 2-fold in both 410 However, we note that the IL-2 production reported in Yang et al was much lower compared 420 to CD25 high FOXP3 − Teffs, and immune subsets were not stratified based on the expression of 421 CD127, CD45RA and HELIOS. It is therefore likely that the residual production of IL-2 422 observed by Yang et al in CD25 low FOXP3 + T cells was due primarily to HELIOS − T cells. In 423 contrast, in our study we demonstrate that CD45RA − CD25 low CD127 low HELIOS + FOXP3 + 424 cells have a profound inability to produce IL-2 as compared to CD127 + CD25 high CD45RA − 425 HELIOS − FOXP3 − Teffs. We also noted the overall heterogeneity in the CD127 low subset in 426 regard to IL-2 and IFN-γ secretion (Fig. 6) . A similar proportion of CD127 low cells lacking both FOXP3 and HELIOS expression secrete IL-2 and IFN-γ as compared to their CD127 + 428 counterparts and are likely effector T cells. In healthy individuals we observed that these 429 putative effector cells are the largest portion of the CD45RA − CD25 low CD127 low gate (Fig.  430   1B) , consistent with previous observations [13] . Baseline characteristics for the study participants stratified by the study cohorts. 1 Newly diagnosed T1D patients (duration of disease <= 3 years) enrolled in the Diabetes -Genes, Autoimmunity and Prevention (D-GAP) study. 2 Long-standing adult T1D patients enrolled from the Cambridge BioResource (CBR). 3 First-degree sibling of a T1D patient, reporting no autoimmune disease and determined to be negative for the following T1D-associated autoantibodies: IAA, IA2, GAD and ZnT8. CID, Combined immunodeficiency; T1D, type 1 diabetes; SLE; systemic lupus erythematosus.
